Viola Risk presents a comprehesive review of Citigroup and utilizes economic earnings and systemic capital shortfall analysis to show its higher risk levels vs. the other Big 4 banks. Sell Stock, be choosy on Buys on Bonds. Regulatory risk High, Counterparty Medium-to-High.
JPMorgan was the first big bank to show the higher reserve action impacts from the COVID-19 pandemic. While there are still many questions as to length and severity, JPM has the economic earnings strength, reserves and capital to weather the difficult environment. Sell on Bonds, Buy Stock, Counterparty & Regulatory risk is Low-to-Medium.
Interest rate risk is the most prominent headwind facing most banks. BAC presents the most details on its derivative strategies to preserve net interest margins. And better organic growth is helping as well. We explore these dynamics from the 10K.
JPMorgan's Investor Days have been so succesful that they may not have them every year. Wow! We explore the bank's huge volume generation capability that stabilizes and allows growth in earnings.
RF continues to be loan challenged and margin squeezed. Fed rates reversal sends it to the swaps sanitorium to preserve margin sanity. Sustainability of loan growth credit quality is questionable.
M&T Bank's 2019 10K shows the power of its CRE franchise that continues to grow. Recreational finance and autos are fast growing consumer lending sectors as well. We explore the concentration risks and hedging/derivative strategies to lock in loan yields and preserve margins.
MS fills in the online trading and deposits gaps with its acquisition of E*TRADE. Kind of pricey, but fits well into their strategic goals. Still a Buy on Stock and benchmark bonds. Counterparty risk stays at Medium level.
AmEx adapting well to the digital playing field and millennial generation preferences in co-branding rewards. Still it remains quite competitive and the cost to play is high. We are a Buy on Stock, Sell on benchmark Bonds. Counterparty/Regulatory Risk is Low to Very Low.
Just when you thought CS was stabilizing, another CEO change occurred. But more abruptly than the last couple of rounds. Still, there is positive strategic and balance sheet improvement that the next CEO can leverage. Buy Bonds, Sell Stock, Improved Regulatory/Counterparty risk to High from Very High.
Barclays showed more resilience in capital markets and parts of card banking. Cost cutting still the key. And, it is resetting its targets to build in more revenues growth in payments, transaction banking and investment & advice. All crowded fields that have other banks looking to do same. Still a Buy on Stock, benchmark Bonds. Counterparty risk still High due to Very High systemic risk.